Clinical Trials · NCT00891553
CR9112792, a Follow-up of Study CR9108963
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- GlaxoSmithKline
- Enrollment
- 171
- Start date
- Mar 2009
- Locations
- 3 sites, Denmark, Norway
- Primary endpoint
- Percent change in BMD, as measured by DXA, at the lumbar spine (L1-L4)